Aviance Capital Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,701
Closed -$473K 216
2018
Q2
$473K Buy
9,701
+464
+5% +$26.3K 0.14% 171
2018
Q1
$579K Buy
9,237
+1,059
+13% +$72.6K 0.17% 146
2017
Q4
$501K Sell
8,178
-854
-9% -$52.8K 0.17% 153
2017
Q3
$604K Sell
9,032
-165
-2% -$11.7K 0.2% 132
2017
Q2
$717K Buy
9,197
+707
+8% +$53.4K 0.23% 120
2017
Q1
$692K Buy
8,490
+946
+13% +$74.5K 0.25% 118
2016
Q4
$543K Buy
+7,544
New +$545K 0.19% 128

Other funds holding CAH

Aviance Capital Partners's CAH Position: Q3 2018 in Review

Aviance Capital Partners sold out of Cardinal Health (CAH) in Q3 2018, closing a stake of 9,701 shares — an estimated $473K sold.

Aviance Capital Partners first reported a position in CAH in Q4 2016 and held it in 7 quarters. The position peaked at $717K in Q2 2017. 685 funds tracked by Wall St. Rank hold CAH as of Q3 2018.

  • Aviance Capital Partners reported no remaining Cardinal Health position as of Q3 2018 after selling out during the quarter.
  • Aviance Capital Partners sold 9,701 Cardinal Health shares in Q3 2018, an estimated $473K.
  • Aviance Capital Partners first reported a position in Cardinal Health in Q4 2016 and held it in 7 quarters.
  • Aviance Capital Partners's Cardinal Health position peaked at $717K in Q2 2017.
  • 685 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2018.

Based on Aviance Capital Partners's 13F filing for Q3 2018, filed 9 Nov 2018.